Development of a Machine Learning Algorithm to Predict Abnormalities in Serum Phosphate in a Large Oncology Cohort.

Journal: JCO clinical cancer informatics
PMID:

Abstract

PURPOSE: Serum phosphate is commonly measured in oncology patients because of the relationship between oncologic conditions and treatments with abnormal phosphate. All patients attending our institution, a large specialist oncology center, have a standardized order set (SOS) measured. This consists of 15 biochemical tests, including serum phosphate. Our aim was to understand if abnormalities in serum phosphate could be predicted, using a machine learning algorithm (MLA) by other interrelated variables in the SOS.

Authors

  • Lauren A Scanlon
    Clinical Outcomes and Data Unit, The Christie NHS Foundation Trust, Manchester, United Kingdom.
  • Phillip J Monaghan
    Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom.
  • Safwaan Adam
    Clinical Outcomes and Data Unit, The Christie NHS Foundation Trust, Manchester, United Kingdom.